Skip to main content

Table 3 ROCa curve analysis of CLASP2 and EMT markers for the discrimination of progression within 2 years

From: CLASP2 is involved in the EMT and early progression after transurethral resection of the bladder tumor

 

AUCb

95% CIc

P

Tumor grade

0.613

0.512–0.708

0.02

CLASP2 mRNA (in tumor)

0.702

0.603–0.788

<0.01

CLASP2 mRNA (in urine)

0.716

0.619–0.801

<0.01

E-cadherin mRNA (in tumor)

0.692

0.593–0.780

<0.01

E-cadherin mRNA (in urine)

0.710

0.612–0.795

<0.01

Vimentin mRNA (in tumor)

0.657

0.544–0.768

0.01

Vimentin mRNA (in urine)

0.687

0.580–0.792

<0.01

Combination of CLASP2 and E-cadherin mRNA (in urine)

0.763

0.662–0.864

<0.01

  1. aROC: receiver operating characteristic
  2. bAUC: area under the curve
  3. cConfidence interval of AUC